Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis - Vis, M; Havaardsholm, E A; Haugeberg, G (Ann Rheum Dis, 2006)
et al.